794 filings
10-Q
2024 Q2
LEXX
Lexaria Bioscience Corp
Quarterly report
9 Apr 24
4:12pm
8-K
LEXX
Lexaria Bioscience Corp
21 Mar 24
Entry into a Material Definitive Agreement
4:37pm
EFFECT
LEXX
Lexaria Bioscience Corp
21 Mar 24
Notice of effectiveness
12:15am
424B3
LEXX
Lexaria Bioscience Corp
20 Mar 24
Prospectus supplement
5:00pm
3
Cabatuan Nelson
15 Mar 24
Lexaria Bioscience / Nelson Cabatuan ownership change
4:22pm
8-K
d6qkl fptqr692e1u
15 Mar 24
Departure of Directors or Certain Officers
4:09pm
8-K
d8v3j3e5x t60n81
1 Mar 24
Other Events
2:28pm
8-K
n7lsfqdj5 smwzgd3
16 Feb 24
Lexaria Announces $3.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
4:30pm
D
e0k6ig
16 Feb 24
$3.60 mm in options, sold $3.60 mm, 2 investors
3:47pm
424B5
7x7oix4
16 Feb 24
Prospectus supplement for primary offering
6:01am
SC 13D/A
9m0xmdyoqylg75 fy0
14 Feb 24
Lexaria Bioscience / Boos Wayne W ownership change
2:20pm
SC 13G/A
caydw fdlm
14 Feb 24
Lexaria Bioscience / Invenomic Capital Management ownership change
12:00pm
8-K
51vknv z89q5z6w
30 Jan 24
Other Events
1:51pm
EFFECT
9xj8sztpyrggk
29 Jan 24
Notice of effectiveness
12:15am
8-K
kkmw2u7k
24 Jan 24
Regulation FD Disclosure
2:12pm
POS AM
oxnn51nm2u
24 Jan 24
Prospectus update (post-effective amendment)
1:33pm
S-8
rk4wp2hb3ykf9d z6mr
18 Jan 24
Registration of securities for employees
2:38pm